Teofilin/efedrin: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
||
Baris 58:
}}
'''Teofilin/efedrin''' ([[Nama
Kombinasi teofilin, efedrin, dan fenobarbital (nama merek Tedral antara lain) juga telah banyak digunakan untuk mengobati asma.<ref name="HendelesWeinberger1980">{{cite journal | vauthors = Hendeles L, Weinberger M | title = Avoidance of adverse effects during chronic therapy with theophylline | journal = European Journal of Respiratory Diseases. Supplement | volume = 109 | issue = | pages = 103–119 | date = 1980 | pmid = 7002576 | doi = | quote = Until recently, combination products containing theophylline, ephedrine, and a "sedative" were the most frequently prescribed bronchodilators in the United States. Several studies, however, have documented that the combination of ephedrine and theophylline produce synergistic toxicity without significantly enhancing the therapeutic efficacy of theophylline alone (Figure 1). }}</ref><ref name="KhouzamTanGill2007">{{cite book | vauthors = Khouzam H, Tan D, Gill T | title=Handbook of Emergency Psychiatry | publisher=Elsevier Health Sciences | year=2007 | isbn=978-0-323-07661-6 | url=https://books.google.com/books?id=Izob_Qe-EKwC&pg=PA53 | access-date=30 August 2024 | page=53}}</ref><ref name="Henzelman1972">{{cite book | vauthors = Heinzelman RV | title=Annual Reports in Medicinal Chemistry | publisher=Elsevier Science | series=ISSN | year=1972 | isbn=978-0-08-058351-8 | url=https://books.google.com/books?id=52joNWUvZakC&pg=PA92 | access-date=30 August 2024 | page=92}}</ref><ref name="ProjectLabel1979" /> Banyak kombinasi tersebut telah dipasarkan dengan berbagai nama merek. Teofilin juga telah dipasarkan dalam kombinasi dengan simpatomimetik seperti efedrin lainnya seperti rasefedrin dan pseudoefedrin dan dengan barbiturat lainnya seperti amobarbital dan butabarbital, di antara obat-obatan lainnya.<ref name="ProjectLabel1979">{{cite book | title=Project Label: Alphabetical Listing by Drug Product | publisher=Department of Justice, Drug Enforcement Administration, Office of Compliance and Regulatory Affairs, Regulatory Support Division, Information Systems Section | year=1979 | url=https://books.google.com/books?id=8HJc_WTwdNsC | access-date=2024-08-31}}</ref> Kombinasi teofilin, efedrin, dan hidroksizin telah dipasarkan dengan nama merek Marax antara lain juga.<ref name="EmergMedCare1983">{{cite book | title=Emergency Medical Care: A Manual for the Paramedic in the Field | publisher=U.S. Department of Transportation, National Highway Traffic Safety Administration | series=Emergency Medical Care: A Manual for the Paramedic in the Field | issue=v. 1 | year=1983 | url=https://books.google.com/books?id=Ljgl1bvwKdwC&pg=RA3-PA33 | access-date=31 August 2024 | page=3-PA33}}</ref><ref name="EmergDepTrends2002">{{cite book | title=Emergency Department Trends from the Drug Abuse Warning Network: Preliminary Estimates January-June 2001 with Revised Estimates 1994-2000 | publisher=Department of Health and Human Services, Substance Abuse and Mental Health Services Administration | series=DHHS publication | issue=v. 3 | year=2002 | url=https://books.google.com/books?id=i4Xhbcw-vK0C&pg=PA210 | access-date=31 August 2024 | page=210}}</ref><ref name="Mosby2016">{{cite book | title=Mosby's Pocket Dictionary of Medicine, Nursing & Health Professions - E-Book: Mosby's Pocket Dictionary of Medicine, Nursing & Health Professions - E-Book | publisher=Elsevier Health Sciences | year=2016 | isbn=978-0-323-41427-2 | url=https://books.google.com/books?id=sH-JDAAAQBAJ&pg=PA810 | access-date=31 August 2024 | page=810}}</ref> Kombinasi teofilin, efedrin, dan barbiturat kemudian dihapuskan demi kombinasi teofilin dan efedrin saja (misalnya, nama merek Franol).<ref name="Head2022" /><ref name="Mansfield1991">{{cite journal | vauthors = Mansfield PR | title = Classifying improvements to drug marketing and justifications for claims of efficacy | journal = The International Journal of Risk & Safety in Medicine | volume = 2 | issue = 4 | pages = 171–184 | date = 1991 | pmid = 23511913 | doi = 10.3233/JRS-1991-2401 | quote = Dr Lathem, Sterling's Vice President for Scientific Affairs replied to MaLAM that "Franol is approved for marketing in the United Kingdom in a formulation containing theophylline and ephedrine. We have initiated a re-formulation worldwide to make all Franol formulations consistent with those of the U.K.". Weinberger and Bronsky (1974) compared theophylline and ephedrine separately and combined. They concluded that "the inclusion of ephedrine resulted in no further benefit but did appear to increase the frequency of adverse effects" [26]. }}</ref> Kombinasi dosis tetap teofilin dan efedrin ditinggalkan setelah tahun 1970-an karena tidak memungkinkan titrasi dosis dalam terapi asma akibat toksisitas efedrin.<ref name="AkazawaStempel2006">{{cite journal | vauthors = Akazawa M, Stempel DA | title = Single-inhaler combination therapy for asthma: a review of cost effectiveness | journal = PharmacoEconomics | volume = 24 | issue = 10 | pages = 971–988 | date = 2006 | pmid = 17002480 | doi = 10.2165/00019053-200624100-00005 | quote = The concept of using a single therapy and maximising the dose of ICS might have been driven by the desire to avoid fixed combinations. These were commonly used in the US during the 1970s with products such as Tedral®1 and Marax® that combined theophylline and ephedrine with a sedative. The earlier fixed combinations did not allow for significant dose titration, due to the toxicity of ephedrine, and thus the concept of fixed dosing combinations for asthma was relegated to an ‘unacceptable’ status. }}</ref>
|